よむ、つかう、まなぶ。
03資料1-1森野委員提出資料（高齢者に対するインフルエンザワクチンファクトシート） (39 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64997.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 予防接種基本方針部会 ワクチン評価に関する小委員会（第32回 10／22）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
48.
Lee JKH, Lam GKL, Shin T, Samson SI, Greenberg DP, Chit A. Efficacy and effectiveness of
high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated
systematic review and meta-analysis. Vaccine 2021; 39 Suppl 1: A24-a35.
49.
Lee JKH, Lam GKL, Yin JK, Loiacono MM, Samson SI. High-dose influenza vaccine in older
adults by age and seasonal characteristics: Systematic review and meta-analysis update. Vaccine X 2023;
14: 100327.
50.
Ferdinands JM, Blanton LH, Alyanak E, et al. Protection against influenza hospitalizations
from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis. J
Am Geriatr Soc 2024; 72(12): 3875-89.
51.
Skaarup KG, Lassen MCH, Modin D, et al. The relative vaccine effectiveness of high-dose vs
standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of
evidence from randomized trials. J Infect 2024; 89(1): 106187.
52.
Balasubramani GK, Choi WS, Nowalk MP, et al. Relative effectiveness of high dose versus
standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
Vaccine 2020; 38(42): 6562-9.
53.
Paudel M, Mahmud S, Buikema A, et al. Relative vaccine efficacy of high-dose versus standard-
dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
Vaccine 2020; 38(29): 4548-56.
54.
DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP.
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and
standard-dose inactivated influenza vaccines. Vaccine 2015; 33(38): 4988-93.
55.
Johansen ND, Modin D, Skaarup KG, et al. Effectiveness of high-dose versus standard-dose
quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza
circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial. Clin Microbiol Infect 2024;
30(11): 1453-9.
56.
Young-Xu Y, Snider JT, van Aalst R, et al. Analysis of relative effectiveness of high-dose versus
standard-dose influenza vaccines using an instrumental variable method. Vaccine 2019; 37(11): 1484-90.
57.
Bricout H, Levant MC, Assi N, et al. The relative effectiveness of a high-dose quadrivalent
influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a
retrospective cohort study during the 2021-2022 influenza season. Clin Microbiol Infect 2024; 30(12):
1592-8.
58.
Doyle JD, Beacham L, Martin ET, et al. Relative and Absolute Effectiveness of High-Dose and
Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United
States, 2015-2017. Clin Infect Dis 2021; 72(6): 995-1003.
59.
Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in
preventing hospitalization among seniors, and observations on the limitations of effectiveness study
design. Vaccine 2018; 36(45): 6683-7.
60.
Schaffner W, Chen WH, Hopkins RH, Neuzil K. Effective Immunization of Older Adults Against
39
Lee JKH, Lam GKL, Shin T, Samson SI, Greenberg DP, Chit A. Efficacy and effectiveness of
high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated
systematic review and meta-analysis. Vaccine 2021; 39 Suppl 1: A24-a35.
49.
Lee JKH, Lam GKL, Yin JK, Loiacono MM, Samson SI. High-dose influenza vaccine in older
adults by age and seasonal characteristics: Systematic review and meta-analysis update. Vaccine X 2023;
14: 100327.
50.
Ferdinands JM, Blanton LH, Alyanak E, et al. Protection against influenza hospitalizations
from enhanced influenza vaccines among older adults: A systematic review and network meta-analysis. J
Am Geriatr Soc 2024; 72(12): 3875-89.
51.
Skaarup KG, Lassen MCH, Modin D, et al. The relative vaccine effectiveness of high-dose vs
standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of
evidence from randomized trials. J Infect 2024; 89(1): 106187.
52.
Balasubramani GK, Choi WS, Nowalk MP, et al. Relative effectiveness of high dose versus
standard dose influenza vaccines in older adult outpatients over four seasons, 2015-16 to 2018-19.
Vaccine 2020; 38(42): 6562-9.
53.
Paudel M, Mahmud S, Buikema A, et al. Relative vaccine efficacy of high-dose versus standard-
dose influenza vaccines in preventing probable influenza in a Medicare Fee-for-Service population.
Vaccine 2020; 38(29): 4548-56.
54.
DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP.
Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and
standard-dose inactivated influenza vaccines. Vaccine 2015; 33(38): 4988-93.
55.
Johansen ND, Modin D, Skaarup KG, et al. Effectiveness of high-dose versus standard-dose
quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza
circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trial. Clin Microbiol Infect 2024;
30(11): 1453-9.
56.
Young-Xu Y, Snider JT, van Aalst R, et al. Analysis of relative effectiveness of high-dose versus
standard-dose influenza vaccines using an instrumental variable method. Vaccine 2019; 37(11): 1484-90.
57.
Bricout H, Levant MC, Assi N, et al. The relative effectiveness of a high-dose quadrivalent
influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a
retrospective cohort study during the 2021-2022 influenza season. Clin Microbiol Infect 2024; 30(12):
1592-8.
58.
Doyle JD, Beacham L, Martin ET, et al. Relative and Absolute Effectiveness of High-Dose and
Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United
States, 2015-2017. Clin Infect Dis 2021; 72(6): 995-1003.
59.
Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in
preventing hospitalization among seniors, and observations on the limitations of effectiveness study
design. Vaccine 2018; 36(45): 6683-7.
60.
Schaffner W, Chen WH, Hopkins RH, Neuzil K. Effective Immunization of Older Adults Against
39